Comorbidities as a Driver of the Excess Costs of Community-Acquired Pneumonia in U.S. Commercially-Insured Working Age Adults

BMC Health Services Research - United Kingdom
doi 10.1186/1472-6963-12-379
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Burden of Community-Acquired Pneumonia in Adults Over 18 Years of Age

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Private Costs of Patients Hospitalized With Community-Acquired Pneumonia

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2005English

Antimicrobial Therapy for Community-Acquired Pneumonia in Adults

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2002English

Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis

PLoS ONE
Multidisciplinary
2012English

Viral and Bacterial Aetiology of Community-Acquired Pneumonia in Adults

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2012English

Chlamydiaspecies as a Cause of Community-Acquired Pneumonia in Canada

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

Community-Acquired Chlamydia Pneumoniae Pneumonia in Japan: A Prospective Multicenter Community-Acquired Pneumonia Study.

Internal Medicine
Internal MedicineMedicine
2002English

Community-Acquired Pneumonia

2010English

Community Acquired Pneumonia

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy